期刊文献+

喉癌组织EGFR、p27和皮层肌动蛋白表达及其与局部复发的关系

Relationship of EGFR,p27 and cortactin expressions in cancer tissues and local recurrence of laryngeal carcinoma
原文传递
导出
摘要 目的探讨喉鳞状细胞癌(LSCC)组织中表皮生长因子受体(EGFR)、p27和皮层肌动蛋白(cortactin)表达与术后肿瘤局部复发的关系。方法采用免疫组化法检测60例喉癌组织原发灶EGFR、p27和皮层肌动蛋白表达情况并进行免疫染色评分。对患者临床病理因素及EGFR、p27和皮层肌动蛋白表达与喉癌术后局部复发情况进行多因素Logistic回归分析。结果多因素分析显示,EGFR、p27和皮层肌动蛋白表达是喉癌术后局部复发的独立影响因素(P=0.020,0.010,0.008),EGFR和皮层肌动蛋白高表达是局部复发的危险因素(β=1.244,1.639),p27高表达是局部复发的保护因素(β=-1.390)。喉癌术后局部复发与年龄、性别、临床分期和病理分化无关。结论EGFR、p27和皮层肌动蛋白表达与喉癌术后局部复发相关。EGFR、p27和皮层肌动蛋白三个因子可能成为预测喉鳞状细胞癌术后复发的生物标记物。 Objective To investigate the relationship of Epidermal growth factor receptor (EGFR), p27 and cortactin expressions in cancer tissues and local recurrence of laryngeal carcinoma. Methods The expressions of EGFR, p27 and cortactin in laryngeal squamous cell carcinoma(LSCC) were detected using immunohistochemistry in 60 patients with LSCC. The immunostaining scores for EGFR, p27 and cortactin were assessed. Multivariate logistic regression model was used to analyze the influence of the clinicopathological parameters and expressions of EGFR, p27and cortactin on local recurrence of LSCC. Results The multivariate analysis showed that the expressions of EGFR, p27 and cortactin in LSCC were independent influential factors for local recurrence(P=0. 020,0. 010,0. 008). Higher expressions of EGFR and cortactin (β=1. 244, 1. 639) and lower expression of p27 (β=-1. 390) were accompanied by higher risk for local recurrence. The local recurrence of LSCC was not significantly correlated with age, gender, tumor stage or grade of tumor differentiation. Conclusion Local recurrence is associated with the expressions of EGFR, p27 and cortactin in LSCC. EGFR, p27 and cortactin may be the possible indicators for local recurrence in LSCC.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第13期1519-1522,共4页 Jiangsu Medical Journal
基金 江苏省卫生厅课题(H200802)
关键词 表皮生长因子受体 P27 皮层肌动蛋白 喉癌 Epidermal growth factor receptor p27 Cortactin Laryngeal squamous cell carcinoma
  • 相关文献

参考文献16

  • 1O-Charoenrat P,Rhys-Evans P,Modjtahedi H,et al.Overexpression of epidermal growth factor receptor inhuman head and neck squamous carcinoma cell linescorrelates with matrix metalloproteinase-9expression and invitro invasion[J].Int J Cancer,2000,86(3):307-317.
  • 2Toyoshima H,Hunter T.p27,a novel inhibitor of G1cyclin-Cdk protein kinase activity,is related to p21[J].Cell,1994,78(1):67-74.
  • 3Susaki E,Nakayama K,Nakayama KI.Cyclin D2translocatesp27out of the nucleus and promotes its degradation at theG0-G1transition[J].Mol Cell Biol,2007,27(13):4626-4640.
  • 4Wu H,Parsons JT.Cortactin,an 80/85-kilodalton pp60srcsubstrate,is a filamentous actin-binding protein enriched inthe cell cortex[J].J Cell Biol,1993,120(6):1417-1426.
  • 5van Rossum AG,Gibcus J,van der Wal J,et al.Cortactinoverexpression results in sustained epidermal growth factorreceptor signaling by preventing ligand-induced receptordegradation in human carcinoma cells[J].Breast Cancer Res,2005,7(6):235-237.
  • 6Williams ME,Gaffey MJ,Weiss LM,et al.Chromosome11Q13 amplification in head and neck squamous cellcarcinoma[J].Arch Otolaryngol Head Neck Surg,1993,119(11):1238-1243.
  • 7Pagano M,Tam SW,Theodoras AM,et al.Role of theubiquitin-proteasome pathway in regulating abundance of thecyclin-dependent kinase inhibitor p27[J].Science,1995,269(5224):682-685.
  • 8Jin YT,Kayser S,Kemp BL,et al.The prognosticsignificance of the biomarkers p21WAF1/CIP1,p53,andbcl-2in laryngeal squamous cell carcinoma[J].Cancer,1998,82(11):2159-65.
  • 9Ciaparrone M,Yamamoto H,Yao Y,et al.Localization andexpression of p27KIP1in multistage colorectal carcinogenesis[J].Cancer Res,1998,58(1):114-122.
  • 10Fredersdorf S,Burns J,Milne AM,et al.High levelexpression of p27kip1 and cyclin D1in some human breastcancer cells:inverse correlation between the expression ofp27kip1 and degree of malignancy in human breast andcolorectal cancers[J].Proc Natl Acad Sci USA,1997,94(12):6380-6385.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部